ENDOLOGIX INC /DE/
CIK 0001013606
Revenue (TTM)
$125.36M
−0.1% YoY
Q1 Aug 2020
Net Income (TTM)
−$79.11M
−0.8% YoY
Q1 Aug 2020
EPS Diluted (TTM)
−$0.14
−37.5% YoY
Q1 Aug 2020
Gross Margin
60.1%
Q1 Aug 2020
Operating Margin
-43.3%
Q1 Aug 2020
Net Margin
-63.1%
Q1 Aug 2020
Free Cash Flow (TTM)
−$46.6M
Q1 Aug 2020
Cash
$18.5M
Q1 Aug 2020
Total Debt
$18.04M
Q1 Aug 2020
Shares Outstanding
20.66M sh
Q1 Aug 2020